(Q53530061)
Statements
Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. (English)
D O'Toole
M Ducreux
G Bommelaer
J L Wemeau
O Bouché
F Catus
J Blumberg
P Ruszniewski
1 February 2000
88
4
770-776